LILRB4 on multiple myeloma cells promotes bone lesion by p-SHP2/NF-κB/RELT signal pathway

Abstract Background Leukocyte Ig-like receptor B family 4 (LILRB4) as an immune checkpoint on myeloid cells is a potential target for tumor therapy. Extensive osteolytic bone lesion is the most characteristic feature of multiple myeloma. It is unclear whether ectopic LILRB4 on multiple myeloma regul...

Cijeli opis

Bibliografski detalji

Glavni autori:	Hongying Wang, Lei Wang, Huiwen Luan, Jing Xiao, Zhiling Zhao, Pengfei Yu, Mi Deng, Yifan Liu, Shuhao Ji, Junjie Ma, Yan Zhou, Jiashen Zhang, Xianhui Meng, Juan Zhang, Xinyu Zhao, Chunling Li, Fangmin Li, Dapeng Wang, Shujuan Wei, Lijun Hui, Siman Nie, Changzhu Jin, Zhiqiang An, Ningyan Zhang, Yaopeng Wang, Cheng Cheng Zhang, Zunling Li
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2024-07-01
Serija:	Journal of Experimental & Clinical Cancer Research
Teme:	LILRB4 Multiple myeloma Bone lesion RELT
Online pristup:	https://doi.org/10.1186/s13046-024-03110-y
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!